Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiomyocytes derived from stem cells.

Linda W Van Laake1, Dennis Van Hoof, Christine L Mummery

  • 1Hubrecht Laboratory (Netherlands Institute for Developmental Biology), Utrecht, Netherlands.

Annals of Medicine
|November 10, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peak Oxygen Uptake for Risk Stratification in Fully Magnetically Levitated Left Ventricular Assist Device Recipients.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Generation of a STRAIGHT-IN Dual AAVS1 hiPSC line with orthogonal landing pads for versatile DNA payload integration.

Stem cell research·2026
Same author

Cardiomyopathy phenotypes caused by a heterozygous MYBPC3 mutation revealed in different hiPSC cardiac models.

Experimental cell research·2026
Same author

Reply to 'Beyond socioeconomic status: structural determinants and strategic approaches to regional variation in left ventricular assist device utilization'.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2026
Same author

In vitro modeling of renal injury-induced cardiac effects using human iPSC-derived organoids.

Cell communication and signaling : CCS·2026
Same author

Environmental risk factors and cardiovascular health.

European heart journal·2026
Same journal

Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial.

Annals of medicine·2026
Same journal

Postoperative outcomes of on- vs off-pump CABG in patients with HFrEF: a nationwide cohort study in Taiwan.

Annals of medicine·2026
Same journal

Population pharmacokinetic-based dose adjustment of tiapride in patients with impaired renal function.

Annals of medicine·2026
Same journal

Association of neutrophil percentage-to-albumin ratio with sepsis in infant.

Annals of medicine·2026
Same journal

Enhancing Hemoglobin Bart's hydrops fetalis syndrome prevention: a single-tube multiplex real-time PCR assay for the comprehensive detection of four significant α<sup>0</sup>-thalassemia deletions (--<sup>SEA</sup>, --<sup>THAI</sup>, --<sup>CR</sup>, and --<sup>SA</sup>) found in Thailand.

Annals of medicine·2026
Same journal

Association of non-insulin-based insulin resistance indices with the risk of aortic stenosis progression in patients with mild or moderate aortic stenosis.

Annals of medicine·2026
See all related articles

Embryonic stem cells and cardiac progenitors are the only proven sources for generating new heart muscle cells. Other stem cell therapies for heart repair may work through different mechanisms, not direct cell replacement.

Area of Science:

  • Cardiology
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Myocardial infarction (heart attack) leads to loss of cardiac cells and impaired heart function.
  • Cell replacement therapy is a potential strategy to restore heart function.
  • Various stem cell sources are being investigated for cardiac repair.

Purpose of the Study:

  • To review stem cell research for cardiac cell replacement.
  • To focus on advancements in producing cardiomyocytes from embryonic stem cells.
  • To evaluate the efficacy of different stem cell sources for heart repair.

Main Methods:

  • Review of current literature on stem cell research for cardiac regeneration.
  • Analysis of laboratory advances in differentiating embryonic stem cells into cardiomyocytes.

Related Experiment Videos

  • Evaluation of clinical findings regarding stem cell therapy for myocardial infarction.

    • Main Results:

    • Embryonic stem cells can be differentiated into cardiomyocytes in laboratory settings.
    • Cardiac progenitor cells residing within the heart are a proven source of cardiomyocytes.
    • Clinical benefits observed from bone marrow stem cell therapy may not be due to direct cardiomyocyte replacement.

    Conclusions:

    • Embryonic stem cells and endogenous cardiac progenitors are the only validated sources for generating new cardiomyocytes.
    • The mechanisms behind the therapeutic effects of bone marrow stem cells in cardiac repair require further investigation and validation.
    • Current evidence suggests that direct cardiac cell replacement is primarily achievable with embryonic stem cells and cardiac progenitors.